TY - JOUR T1 - UK survey of <em>Pneumocystis jirovecii</em> Pneumonia (PJP) prophylaxis use in paediatric oncology patients JF - Archives of Disease in Childhood JO - Arch Dis Child SP - 115 LP - 115 DO - 10.1136/archdischild-2014-307515 VL - 100 IS - 1 AU - Rebecca Proudfoot AU - Rachel Cox AU - Bob Phillips AU - Sophie Wilne Y1 - 2015/01/01 UR - http://adc.bmj.com/content/100/1/115.abstract N2 - Pneumocystis jirovecii, previously known as Pneumocystis cariniii , is an opportunistic parasite that causes P. jirovecii pneumonia (PJP) in immunocompromised hosts. Most immunocompetent children acquire asymptomatic infection with P. jirovecii by the age of 4 years,1 while symptomatic disease occurs almost exclusively in severely immunocompromised hosts.Pneumocystis has been recognised as a cause of pneumonia since the 1940s when epidemics of ‘plasma cell pneumonia’ were diagnosed in malnourished and premature infants in care homes in Eastern Europe.2 In the 1960s, as immunosuppressive therapy for malignancy … ER -